Clinical Trials Browser

Phase 4 × disitamab vedotin × Genitourinary × Clear all

NCT05723991 2023-02-13

Study of Disitamab Vedotin Combined With Gemcitabine in Neoadjuvant Treatment of Urothelial Carcinoma

Phase 4 Unknown

Carcinoma, Transitional Cell

NCT05488353 2022-08-04

A Clinical Study of Disitamab Vedotin for Injection Combined With Penpulimab Injection in Neoadjuvant Therapy for Patients With HER2-expressing Cisplatin-intolerant cT2-T4aNxM0 Bladder Urothelial Carcinoma

Phase 4 Not yet recruiting

Urinary Bladder Neoplasms